TY - JOUR
T1 - Effects of mandibular advancement device for obstructive sleep apnea on temporomandibular disorders
T2 - A systematic review and meta-analysis
AU - Alessandri-Bonetti, Anna
AU - Bortolotti, Francesco
AU - Moreno-Hay, Isabel
AU - Michelotti, Ambra
AU - Cordaro, Massimo
AU - Alessandri-Bonetti, Giulio
AU - Okeson, Jeffrey P.
N1 - Publisher Copyright:
© 2019 Elsevier Ltd
PY - 2019/12
Y1 - 2019/12
N2 - The clinical practice guidelines do not give precise indications on the use of mandibular advancement devices (MAD) for obstructive sleep apnea (OSA) patients when they suffer from temporomandibular disorders (TMD). The aim of this systematic review was to evaluate the effects of MADs on prevalence of TMD signs and symptoms in adult OSA patients. The study protocol was registered under the PROSPERO register and an electronic search was performed in several databases. All types of studies evaluating TMD prevalence on adult patients wearing MAD for OSA were included and independently evaluated by two investigators. The quality of evidence was evaluated using the grading of recommendations assessment, development and evaluation and the risk of bias by the risk of bias in non-randomized studies of interventions tool or the Cochrane collaboration's tool. For each study included, the difference in means and 95% CI was calculated between baseline and follow-up. Twelve studies were included. The meta-regression analysis showed that patients with pre-existing signs and symptoms of TMD do not experience significant exacerbation of symptoms using the MAD. The presence of TMD does not appear to be routine contraindication for the use of MAD used for the management of OSA.
AB - The clinical practice guidelines do not give precise indications on the use of mandibular advancement devices (MAD) for obstructive sleep apnea (OSA) patients when they suffer from temporomandibular disorders (TMD). The aim of this systematic review was to evaluate the effects of MADs on prevalence of TMD signs and symptoms in adult OSA patients. The study protocol was registered under the PROSPERO register and an electronic search was performed in several databases. All types of studies evaluating TMD prevalence on adult patients wearing MAD for OSA were included and independently evaluated by two investigators. The quality of evidence was evaluated using the grading of recommendations assessment, development and evaluation and the risk of bias by the risk of bias in non-randomized studies of interventions tool or the Cochrane collaboration's tool. For each study included, the difference in means and 95% CI was calculated between baseline and follow-up. Twelve studies were included. The meta-regression analysis showed that patients with pre-existing signs and symptoms of TMD do not experience significant exacerbation of symptoms using the MAD. The presence of TMD does not appear to be routine contraindication for the use of MAD used for the management of OSA.
KW - Mandibular advancement device
KW - Obstructive sleep apnea
KW - Oral appliances
KW - Sleep disorders
KW - Temporomandibular disorders
UR - http://www.scopus.com/inward/record.url?scp=85072922740&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85072922740&partnerID=8YFLogxK
U2 - 10.1016/j.smrv.2019.101211
DO - 10.1016/j.smrv.2019.101211
M3 - Review article
C2 - 31605905
AN - SCOPUS:85072922740
SN - 1087-0792
VL - 48
JO - Sleep Medicine Reviews
JF - Sleep Medicine Reviews
M1 - 101211
ER -